Currently there are no primary preventives for atrial fib, but the prediction model could help identify high-risk candidates for primary-prevention trials, researchers say.
Heartwire
Pain relief with acupuncture is only slightly better than that achieved with sham, or "placebo," acupuncture, new research suggests.
Medscape Medical News
Not only Amish-Mennonites but also families of other ancestry demonstrate the influence of THAP1 mutations in primary torsion dystonia.
Medscape Medical News
In 2 studies, the ProDisc-L was superior to spinal-fusion surgery in relieving disability and improving patient quality of life, and it resulted in fewer reoperations.
Medscape Medical News
Review the challenges of treating a patient with chronic pain and with a history of substance abuse and evaluate interventions that are available or are in development.
Combining transcranial Doppler ultrasound with microspheres and tissue plasminogen activator is more effective than tPA alone in treating ischemic stroke.
Medscape Medical News
A new study sheds light on how cellular changes in the sleeping brain promote the formation of memories.
Medscape Medical News
The FDA says that a boxed warning about the risk for tardive dyskinesia during long-term or high-dose use must be added to the drug labels of metoclopramide-containing drugs.
Medscape Medical News
Circulation editors have asked the authors of the MIST trial to clarify aspects of the paper and publish a correction. Separately, an advisor to the UK National Research Ethics Service has recommended an investigation of the much-disputed echocardiographic follow-up of patients who underwent PFO closure in MIST.
Heartwire
Results of a phase 3 randomized trial show fampridine, an oral potassium-channel blocker, improved walking ability in some patients with multiple sclerosis, regardless of disease subtype or concomitant therapy.
Medscape Medical News